FI964083A - Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä - Google Patents

Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä Download PDF

Info

Publication number
FI964083A
FI964083A FI964083A FI964083A FI964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A FI 964083 A FI964083 A FI 964083A
Authority
FI
Finland
Prior art keywords
lipid
outermost
lipid bilayer
liposome
bilayer
Prior art date
Application number
FI964083A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964083A0 (fi
Inventor
Austin Bailey
Pieter R Cullis
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of FI964083A publication Critical patent/FI964083A/fi
Publication of FI964083A0 publication Critical patent/FI964083A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964083A 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä FI964083A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003996 WO1995027478A1 (en) 1994-04-12 1994-04-12 Fusogenic liposomes and methods of making and using same

Publications (2)

Publication Number Publication Date
FI964083A true FI964083A (fi) 1996-10-11
FI964083A0 FI964083A0 (fi) 1996-10-11

Family

ID=22242444

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964083A FI964083A0 (fi) 1994-04-12 1996-10-11 Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä

Country Status (13)

Country Link
EP (1) EP0758883B1 (es)
JP (1) JP3804025B2 (es)
KR (1) KR100315132B1 (es)
AT (1) ATE234605T1 (es)
AU (1) AU689479B2 (es)
CA (1) CA2187748C (es)
DE (1) DE69432320T2 (es)
DK (1) DK0758883T3 (es)
ES (1) ES2196028T3 (es)
FI (1) FI964083A0 (es)
NO (1) NO318814B1 (es)
NZ (1) NZ268146A (es)
WO (1) WO1995027478A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339069B1 (en) 1996-10-15 2002-01-15 Elan Pharmaceuticalstechnologies, Inc. Peptide-lipid conjugates, liposomes and lipsomal drug delivery
WO1998016240A1 (en) * 1996-10-15 1998-04-23 The Liposome Company, Inc. Peptide-lipid conjugates, liposomes and liposomal drug delivery
JP4656675B2 (ja) 1997-05-14 2011-03-23 ユニバーシティー オブ ブリティッシュ コロンビア 脂質小胞への荷電した治療剤の高率封入
US6835395B1 (en) 1997-05-14 2004-12-28 The University Of British Columbia Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
EP1212085B1 (en) * 1999-08-27 2007-10-31 INEX Pharmaceuticals Corp. Compositions for stimulating cytokine secretion and inducing an immune response
KR20060034215A (ko) * 2003-03-31 2006-04-21 알자 코포레이션 비대칭 지질 코팅을 가지는 지질 입자 및 그 제조 방법
EP2669002A1 (en) * 2005-01-28 2013-12-04 Japan Science and Technology Agency Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
JP5532921B2 (ja) 2007-05-14 2014-06-25 コニカミノルタ株式会社 リポソーム
US9937128B2 (en) 2009-08-03 2018-04-10 The University Of North Carolina At Chapel Hill Liposomes comprising a calcium phosphate-containing precipitate
PT3338765T (pt) 2009-12-01 2019-03-18 Translate Bio Inc Derivado de esteróide adequado para a administração de arnm em doenças genéticas humanas
AU2012267531B2 (en) 2011-06-08 2017-06-22 Translate Bio, Inc. Lipid nanoparticle compositions and methods for mRNA delivery
EP3536787A1 (en) 2012-06-08 2019-09-11 Translate Bio, Inc. Nuclease resistant polynucleotides and uses thereof
HUE042640T2 (hu) 2013-03-14 2019-07-29 Translate Bio Inc CFTR-mRNS-készítmények, valamint kapcsolódó eljárások és alkalmazások
JP6586075B2 (ja) 2013-03-14 2019-10-02 トランスレイト バイオ， インコーポレイテッド メッセンジャーｒｎａの精製方法
EP3060258A1 (en) 2013-10-22 2016-08-31 Shire Human Genetic Therapies, Inc. Mrna therapy for phenylketonuria
ES2707966T3 (es) 2013-10-22 2019-04-08 Translate Bio Inc Terapia de ARNm para la deficiencia en síntesis de argininosuccinato
KR20220158867A (ko) 2014-04-25 2022-12-01 샤이어 휴먼 지네틱 테라피즈 인크. 메신저 rna 의 정제 방법
EP3585417B1 (en) 2017-02-27 2023-02-22 Translate Bio, Inc. Method of making a codon-optimized cftr mrna
WO2018213476A1 (en) 2017-05-16 2018-11-22 Translate Bio, Inc. Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
CA3108544A1 (en) 2018-08-24 2020-02-27 Translate Bio, Inc. Methods for purification of messenger rna

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) * 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
EP0269720B1 (en) * 1986-06-16 1992-02-19 The Liposome Company, Inc. Induction of asymmetry in vesicles
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
DE4013632A1 (de) * 1990-04-27 1991-10-31 Max Planck Gesellschaft Liposomen mit positiver ueberschussladung
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells

Also Published As

Publication number Publication date
NZ268146A (en) 1997-10-24
EP0758883B1 (en) 2003-03-19
NO318814B1 (no) 2005-05-09
AU689479B2 (en) 1998-04-02
NO964284L (no) 1996-10-09
CA2187748A1 (en) 1995-10-19
DE69432320T2 (de) 2003-12-04
EP0758883A1 (en) 1997-02-26
JP3804025B2 (ja) 2006-08-02
DE69432320D1 (de) 2003-04-24
KR100315132B1 (ko) 2002-06-26
JPH09511521A (ja) 1997-11-18
ES2196028T3 (es) 2003-12-16
AU7091594A (en) 1995-10-30
FI964083A0 (fi) 1996-10-11
WO1995027478A1 (en) 1995-10-19
ATE234605T1 (de) 2003-04-15
CA2187748C (en) 2007-04-10
DK0758883T3 (da) 2003-06-02
NO964284D0 (no) 1996-10-09

Similar Documents

Publication Publication Date Title
FI964083A (fi) Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä
Hofland et al. Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro
ES2167308T3 (es) Un sistema de distribucion de fosfolipidos.
AU1724097A (en) Lipids and their use, for example, in liposomes
DE69923181D1 (de) Temperatursensitive liposomale formulierung
ES2123284T3 (es) Un sistema de suministro liposomico para agentes biologicamente activos.
AU4711296A (en) Method for loading lipid vesicles
CA2013755A1 (en) Medicinal emulsions
DE69425901D1 (de) Vesikel mit gesteuerter wirkstofffreisetzung
EP0171710A3 (en) Process for preparing liposome composition
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
ES2118677T3 (es) Una composicion que comprende un agente activo disuelto en un vehiculo formador de vidrio y un procedimiento para su preparacion.
WO1998019709A3 (en) Cationic reagents for transfection
HU9203141D0 (en) Synthetican membrane bubbles containing functionally active fusional peptones being medicament transferring systems
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
ES8608862A1 (es) Un procedimiento para estabilizar particulas micelares y aumentar su duracion en estado preparado.
ATE260643T1 (de) System zur verabreichung makromolekularer wirkstoffe auf der basis von membran-mimetischen amphiphilen in aerosolform
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
AU2520595A (en) Virosome-mediated intracellular delivery of therapeutic agents
KR920002165A (ko) 리포좀 생성물
FI103178B1 (fi) Menetelmä vaikuttavaa ainetta sisältävien vesipohjaisten liposomisuspensioiden valmistamiseksi
GEP19991819B (en) Method for Production of Therapeutic Form of Carbamazepin with Retarded Active Substance Release
GB9827034D0 (en) Delivery formulation

Legal Events

Date Code Title Description
MA Patent expired